TDRD9 抗体 (AA 801-900)
Quick Overview for TDRD9 抗体 (AA 801-900) (ABIN1385847)
抗原
See all TDRD9 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 801-900
-
预测反应
- Human,Mouse,Rat,Dog,Cow,Horse
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human TDRD9/HIG1
-
亚型
- IgG
-
-
-
-
应用备注
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- TDRD9 (Tudor Domain Containing 9 (TDRD9))
-
别名
- TDRD9/HIG1
-
背景
-
Synonyms: C14orf75, chromosome 14 open reading frame 75, HIG 1, Hypoxia inducible HIG 1, MGC135025, Putative ATP dependent RNA helicase TDRD9, Putative ATP-dependent RNA helicase TDRD9, TDRD 9, Tdrd9, TDRD9_HUMAN , Tudor domain containing 9, Tudor domain containing protein 9, Tudor domain-containing protein 9.
Background: Probable ATP-binding RNA helicase which plays a central role during spermatogenesis by repressing transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Its association with PIWIL4 and the piP-bodies suggests a participation in the secondary piRNAs metabolic process.
-
基因ID
- 122402
抗原
-